Cargando…
Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan
BACKGROUND: Primary tumor location is a critical prognostic factor that also impacts the efficacy of anti-epidermal growth factor receptor (EGFR) therapy in wild-type RAS (KRAS/NRAS) metastatic colorectal cancer (CRC). However, the association between the incidence of BRAF and phosphatidylinositol-4...
Autores principales: | Taniguchi, Hiroya, Uehara, Keisuke, Nakayama, Goro, Nakayama, Hiroshi, Aiba, Toshisada, Hattori, Norifumi, Kataoka, Masato, Nakano, Yasuyuki, Kawase, Yoshihisa, Okochi, Osamu, Matsuoka, Hiroshi, Utsunomiya, Setsuo, Sakamoto, Eiji, Mori, Yoshinori, Umeda, Shinichi, Shikano, Toshio, Komori, Koji, Tajika, Masahiro, Kadowaki, Shigenori, Muro, Kei, Yatabe, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232108/ https://www.ncbi.nlm.nih.gov/pubmed/32428838 http://dx.doi.org/10.1016/j.tranon.2020.100786 |
Ejemplares similares
-
The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation
por: Mitani, Seiichiro, et al.
Publicado: (2019) -
Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
por: Hattori, Norifumi, et al.
Publicado: (2019) -
Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma
por: Kadowaki, Shigenori, et al.
Publicado: (2013) -
Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy
por: Kadowaki, Shigenori, et al.
Publicado: (2014) -
Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy
por: Mitani, Seiichiro, et al.
Publicado: (2016)